Hemorragia alveolar difusa como forma de presentación de lupus eritematoso sistémico asociado a tiroiditis autoinmune
Keywords:
Hemorragia alveolar, lúpus eritematoso sistémico, tiroiditis autoinmune, enfermedad autoinmuneAbstract
El lupus eritematoso sistémico es una enfermedad inflamatoria crónica de naturaleza autoinmune, de etiología desconocida en la que hay daño celular y tisular por autoanticuerpos y que cursa con un amplio espectro de manifestaciones clínicas. La hemorragia alveolar difusa es una forma de presentación poco frecuente en pacientes con lupus eritematoso sistémico, raramente debuta como una manifestación inicial de la enfermedad. Aproximadamente 2 % de todos los pacientes con lupus eritematoso sistémico presentan este cuadro, siendo su asociación con otras enfermedades de origen inmune, entre ellas la tiroiditis autoinmune un caso excepcional con elevada mortalidad.Downloads
References
Ong SG, Choy CH. Autoimmune thyroid disease in a cohort of Malaysian SLE patients: frequency, clinical and immunological associations. Lupus 2015; 0: 1–8.
Alves C, Vicente T, Fragomeni M. Diagnosis of juvenile systemic lupus erythematosus in adolescents with hashimoto thyroiditis:Two case reports. Acta reumatol Port. 2010;35(3):362-65.
Watad A, Cohen AD, Comaneshter D, Tekes-Manova D, Amital H. Hyperthyroidism association with SLE, lessons from real-life data. A case–control study. Autoimmunity. 2015;14:1-4.
Hamza RT, Awwad KS, Temsah KA, Hamed AI. Polymorphism of protein tyrosine phosphatase PTPN22 in Egyptian children and adolescents with systemic lupus erythematosus: relation to thyroid autoimmunity. Int J Adolesc Med Health. 2013; 25(2):143-149.
Mader R, Mishail S, Adawi M, Lavi I, Luboshitzky. R. Thyroid dysfunction in patients with systemic lupus erythematosus (SLE): relation to disease activity. Clin Rheumatol. 2007; 26(11):1891-4.
Kumar K, Kumar A, Sarathi Karmakar P, Ghosh A. The spectrum of thyroid disorders in systemic lupus erythematosus. Rheumatol Int. 2012; 32:73–78.
Martínez-Martínez M, Abud-Mendoza C. Hemorragia alveolar difusa en pacientes con lupus eritematoso sistémico. Manifestaciones clínicas, tratamiento y pronóstico. Reumatol Clin. 2014;10:248–253.
Khor CG, Kan SL, Tan BE. Int J Rheum Dis. 2014 Feb 3. doi: 10.1111/1756-185X.12302
Lara A, Schwarz M. Diffuse Pulmonary manifestation as initial presentation for systemic lupus erythematosus. Alveolar Hemorrhage. Chest. 2010;137:1164–1171.
Kamen D, Strange C. Pulmonary manifestations of systemic lupus erythematosus, Clin Chest Med, 2010; 31(3):479–488.
Shen M, Zeng X, Tian X, Zhang F, Zeng X, Zhang X, Xu W. Diffuse alveolar hemorrhage in systemic lupus erythematosus: a retrospective study in China. Lupus 2010; 19(11): 1326-30.
Martínez-Martínez, Abud-Mendoza C. Predictors of mortality in diffuse alveolar haemorrhage associated with systemic lupus erythematosus. Lupus. 2011; 20:56 8–74.
Rojas-Serrano J, Pedroza J, Regalado J, Robledo J, Reyes E, Sifuentes-Osornio J, et al. High prevalence of infections in patients with systemic lupus erythematosus and pulmonary haemorrhage. Lupus 2008; 17(4): 295-9.
Kasturi S, Sammaritano LR. Corticosteroids in Lupus. Rheum Dis Clin North Am. 2016;42(1):47-62.
Parker BJ, Bruce IN. High dose methylprednisolone therapy for the treatment of severe systemic lupus erythematosus. Lupus 2007; 16(6):387-393.
Krause M, Cartin-Ceba R, Specks U, Peikert T. Update on Diffuse Alveolar Hemorrhage and Pulmonary Vasculitis. Immunol Allergy Clin North Am. 2012; 32(4):587–600.
Andrade C, Mendonça T, Farinha F, Correia J, Marinho A, Almeida I, et al. Alveolar hemorrhage in systemic lupus erythematosus: a cohort review. Lupus. 2016; 25(1):75-80.
Rekha Hans, Ratti Sharma, Neelam Marwaha. Dramatic response to plasma exchange in systemic lupus erythematosus with acute complications: Report of two cases. Indian J Crit Care Med. 2013;17(6):385-7.
Pons-Estel GJ, Salerni GE, Serrano RM, Gomez-Puerta JA, Plasin MA, Aldasoro E et al. Therapeutic plasma exchange for the management of refractory systemic. Autoimmun Rev. 2011;10(11):679-84.
Braun-Moscovici Y, Butbul-Aviel Y, Guralnik L, Toledano K, Markovits D, Rozin A, et al. A Rituximab: rescue therapy in life- threatening complications or refractory autoimmune diseases: a single center experience. Rheumatol Int. 2013; 33:1495- 1504.
Published
How to Cite
Issue
Section
License
Warning of rights of author
The authors that publish in this journal agree with the following terms:
The authors conserve the rights of author and concede to the journal the right of the first publication, fulfilling with the license Creative Commons Attribution License that allows to others share the work with recognition of the authorship of their articles, and the initial publication in this journal.
The authors can establish separately additional agreements for the no exclusive distribution of the version of the work published in the journal (for example, situate it in an institutional repository, in a personal blog or publish it partial or totally in a book), with a recognition of their initial publication in this journal.
To be able to send the manuscript or part of him passed three months of published, for his evaluation to other publishers, identifying it or not with the same title; whenever allusion is made to our journale and know it the new publisher.
The publishing committee of the Cuban Journal of Rheumatology authorizes to other publishers, to reproduce the articles published in our magazine, whenever it indicate the origin of the same.
The authors should send a document in Office Word application format through the electronic address of the magazine with a similar format to that we include next:
---------------------------------------------------------------------------------------------------------------------
Statement of authorship and cede of articles for the publication of the scientific work in the Cuban Journal of Rheumatology
Date:
Those who subscribe certify that are the authors of the work:
Of this form communicate the originality of our article clearing that the concepts and knowledges of other authors that have included in the text of the article, have been quoted properly in the bibliography.
We do proof besides that the article in question is original and has not been published, total neither partially, in another journal.
To be approved for his publication in the Cuban Journal of Rheumatology, do secession of the rights of publication to the same one through the method that realizes it usually.
In front of any catchword that exist by the article that send to evaluate, relieve of of the responsibility to the Cuban Journal of Rheumatology holding us responsible with all the difficulties that can berelated by any situation.
We include to continuation the name and the signature of all authors and collaborators of this article.
Name: Signature:
